courses

Janice Hogan , JD

Managing Partner
Hogan & Hartson LLp
Philadelphia, PA

Janice Hogan is the Managing Partner of the Philadelphia office and her practice focuses primarily on the representation of medical device, pharmaceutical, and biological product manufacturers before the U.S. Food and Drug Administration (FDA).

Janice is a biomedical engineer and focuses on regulatory counseling related to high technology medical products. Prior to becoming an attorney, she held positions in marketing/ marketing research for a major pharmaceutical manufacturer. She has authored articles regarding orphan drug regulation and medical device products liability. She is currently authoring articles regarding the use of finite element analysis and other engineering modeling methods in FDA submissions, as well as the interface between FDA regulatory and reimbursement considerations in the design of medical product clinical trials. She has authored a chapter of a recent textbook, Promotion of Biomedical Products (FDLI 2006) and is authoring a chapter of a forthcoming textbook on the regulation of orthopedic implants. Janice has served as an adjunct professor at the University of the Sciences in Philadelphia and as a guest lecturer at Drexel University. She is also a frequent lecturer at FDA regulatory law symposia and conferences on topics related to premarket approval of medical products, combination products regulation, and product development.

Janice formerly served as a law clerk to The Honorable Irma S. Raker of the Maryland Court of Appeals.

HOGAN & HARTSON PUBLICATIONS
"GAO Report Urges the FDA to Issue Regulations Addressing Class III Products in 510(k) Pathway." Medical Device Update, Hogan & Hartson LLP (01.27.2009)

PUBLISHED WORKS
"Standards for Clearance of 501(k) Premarket Notifications in the US." RAJ Devices, Informa UK Ltd (10.01.2008)

Contact Information

1835 Market Street, 28th floor
Philadelphia, PA

JMHogan@HHLAW.com

Category

Research Interests

Representation of medical device, pharmaceutical, and biological product manufacturers before the U.S. Food and Drug Administration (FDA).

Links